Rosuvastatin in the long-term treatment of hypercholesterolaemic subjects with coronary heart disease

Study identifier:D3565L00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A study to evaluate the efficacy and safety of rosuvastatin in the long-term treatment of hypercholesterolaemic subjects with coronary heart disease as measured by intravascular ultrasonography

Medical condition

Hypercholesteremia

Phase

Phase 4

Healthy volunteers

No

Study drug

Rosuvastatin, HMG CoA inhibitor

Sex

All

Actual Enrollment

214

Study type

Interventional

Age

20 Years - 75 Years

Date

Study Start Date: 01 Oct 2005
Primary Completion Date: 01 Oct 2008
Study Completion Date: 01 Oct 2008

Study design

Allocation: Non-randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Aug 2011 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

Shionogi Co.Ltd

Inclusion and exclusion criteria